Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the incidence of complications with the isolated Roux-en-Y reconstruction after pancreaticoduodenectomy in pancreatic tumor and periampullary tumor patients. A prospective randomized controlled trial was conducted to compare the incidence of complications with isolated Roux-en-Y reconstruction with those of Billroth-II-type reconstruction after pancreaticoduodenectomy.
| Condition | Intervention |
|---|---|
|
Pancreatic Neoplasms Bile Duct Neoplasms Ampullary Neoplasms Duodenal Neoplasms Pancreatitis |
Procedure: Billroth-II-type reconstruction Procedure: Isolated Roux-en-Y type reconstruction |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective Randomized Controlled Trial Comparing Isolated Roux-en-Y Reconstruction With Billroth-II-type Reconstruction After Pancreaticoduodenectomy |
- the incidence of pancreatic fistula [ Time Frame: 3 months after operation ] [ Designated as safety issue: Yes ]
- the incidence of other postoperative complications, mortality, delayed gastric emptying, intra-abdominal hemorrhage, and intra-abdominal abscess [ Time Frame: 3 months after operation ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 150 |
| Study Start Date: | June 2009 |
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Billroth-II-type
Billroth-II-type reconstruction after pancreaticoduodenectomy
|
Procedure: Billroth-II-type reconstruction
surgical procedure
Other Name: Child reconstruction
|
|
Experimental: Isolated Roux-en-Y
Isolated Roux-en-Y type reconstruction after pancreaticoduodenectomy
|
Procedure: Isolated Roux-en-Y type reconstruction
surgical procedure
Other Name: Roux-en-Y reconstruction
|
Detailed Description:
The purpose of this study is to clarify whether isolated Roux-en-Y reconstruction declines the incidence of postoperative complications after pancreaticoduodenectomy compared with Billroth-II-type reconstruction. Especially, it is important to decline the incidence of pancreatic fistula, because pancreatic fistula affects a postoperative course. However, there is no report that demonstrated postoperative complications of isolated Roux-en-Y compared with those of Billroth-II-type reconstruction. We conducted a prospective randomized trial on patients who underwent pancreaticoduodenectomy.
Patients with pancreatico-biliary disease who were performed pancreaticoduodenectomy at Wakayama Medical University Hospital.
The primary endpoint was defined as the incidence of pancreatic fistula. The secondary endpoints were the incidence of other postoperative complications, mortality, delayed gastric emptying, intra-abdominal hemorrhage, and intra-abdominal abscess. Patients were recruited into this study before surgery, on the basis of whether pancreatic head resection was anticipated at Wakayama Medical University Hospital (WMUH) for pancreatic head and periampullary disease, and appropriate informed consent was obtained. Exclusion criteria was 1) young patients (less than 20-year-old), 2) patients with severe complications which were possible to prolong hospital stay, 3) patients undergone hemodialysis, 4) patients combined resection of other organs, 5) patients who were diagnosed inadequacy for this study by a physician, and 6) patients without an informed consent.
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- the patients had undergone pancreatic head resection at Wakayama Medical University the patients obtained appropriate informed consent
Exclusion Criteria:
- young patients (less than 20-years-old)
- patients with severe complications which were possible to prolong hospital stay
- patients undergone hemodialysis
- patients combined resection of other organs
- patients who were diagnosed inadequacy for this study by a physician
- patients without an informed consent
Contacts and Locations| Contact: Hiroki Yamaue, MD | 81-73-441-0612 | yamaue-h@wakayama-med.ac.jp |
| Japan | |
| Wakayama Medical University , Second Department of Surgery | Recruiting |
| 811-1 Kimiidera, Wakayama, Wakayama, Japan, 641-8510 | |
| Contact: Hiroki Yamaue, MD +81-73-441-0612 yamaue-h@wakayama-med.ac.jp | |
| Contact: Masaji Tani, MD +81-73-441-0613 matani@wakayama-med.ac.jp | |
| Principal Investigator: Masaji Tani, MD | |
| Study Chair: | Masaji Tani, MD | Wakayama Medical University |
More Information
Publications:
| Responsible Party: | Second Department of Surgery, Wakayama Medical University |
| ClinicalTrials.gov Identifier: | NCT00915863 History of Changes |
| Other Study ID Numbers: | WP-0901 |
| Study First Received: | May 22, 2009 |
| Last Updated: | January 25, 2010 |
| Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Keywords provided by Wakayama Medical University:
|
pancreaticoduodenectomy pancreatic fistula reconstruction isolated Roux-en-Y |
Additional relevant MeSH terms:
|
Bile Duct Neoplasms Neoplasms Duodenal Neoplasms Pancreatic Neoplasms Pancreatitis Biliary Tract Neoplasms Digestive System Neoplasms Neoplasms by Site Bile Duct Diseases Biliary Tract Diseases |
Digestive System Diseases Intestinal Neoplasms Gastrointestinal Neoplasms Gastrointestinal Diseases Duodenal Diseases Intestinal Diseases Endocrine Gland Neoplasms Pancreatic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013